Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes.

Annals of surgical oncology·2022
Same author

Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.

Experimental and molecular pathology·2022
Same author

Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.

Neuroendocrinology·2022
Same author

VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.

Molecular cancer research : MCR·2022
Same author

PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.

Cancers·2022
Same author

Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.

Advances in experimental medicine and biology·2022
Same journal

Advances in virtual screening.

Drug discovery today. Technologies·2024
Same journal

Integration of virtual and physical screening.

Drug discovery today. Technologies·2024
Same journal

A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development.

Drug discovery today. Technologies·2021
Same journal

Mass spectrometry based approaches and strategies in bioanalysis for qualitative and quantitative analysis of pharmaceutically relevant molecules.

Drug discovery today. Technologies·2021
Same journal

Drug discovery from natural products using affinity selection-mass spectrometry.

Drug discovery today. Technologies·2021
Same journal

Editorial for the role(s) of MS in drug research and development.

Drug discovery today. Technologies·2021
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

25.2K

Tissue microarrays for early target evaluation.

Ronald Simon1, Martina Mirlacher1, Guido Sauter1

  • 1Division of Molecular Pathology, Institute of Pathology, Basel University Hospital, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland.

Drug Discovery Today. Technologies
|July 2, 2014
PubMed
Summary
This summary is machine-generated.

Tissue microarray technology enables large-scale molecular epidemiology studies. This approach aids early drug development by assessing target importance, market potential, and side effects for better risk management.

More Related Videos

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
09:08

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas

Published on: May 31, 2012

56.9K
Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer
12:03

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer

Published on: June 10, 2022

14.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

25.2K
Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
09:08

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas

Published on: May 31, 2012

56.9K
Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer
12:03

Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer

Published on: June 10, 2022

14.4K

Area of Science:

  • Translational research
  • Molecular epidemiology
  • Drug development

Background:

  • Strategic decision-making in drug development requires early assessment of biological target importance, market size, and potential side effects.
  • Risk management is crucial for successful new drug development.
  • Comprehensive molecular epidemiology analysis using human tissues is vital for informed strategic decisions.

Purpose of the Study:

  • To highlight the utility of tissue microarray (TMA) technology for large-scale molecular epidemiology.
  • To demonstrate how TMA enables efficient translational research for drug development.

Main Methods:

  • Utilizing tissue microarray (TMA) technology for simultaneous analysis of thousands of human tissues.
  • Conducting comprehensive molecular epidemiology analyses on well-characterized human tissues.

Main Results:

  • TMA technology facilitates highly standardized, fast, and affordable translational research.
  • Large-scale molecular epidemiology studies provide vital data for strategic decision-making in drug development.

Conclusions:

  • Tissue microarray technology is ideally suited for unprecedented scale translational research.
  • This approach significantly enhances the early assessment of drug targets and potential therapeutics, improving risk management in drug development.